Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Germany), Germany, covering academic research published from 2006 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
51
Total Open
Publications
27
Total
Citations
1.4K
Open Access
Percentage
53%
Total
Publications
51
Total Open
Publications
27
Total
Citations
1.4K
Breakdown
Publisher Open
20%
Both
23%
Other Platform Open
10%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 18%
4
Hybrid 46%
10
No Guarantees 36%
8
Other Platform Open
Domain 65%
11
Institution 35%
6
Public 12%
2
Other Internet 12%
2
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 11 |
Europe PMC | Domain | 6 |
University of Bristol - Bristol Research | Institution | 2 |
Semantic Scholar | Public | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Inria | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
University of California - eScholarship University of California | Institution | 1 |
University of Antwerp - Institutional Repository University of Antwerp | Institution | 1 |
unifesp.br OAI-PMH Repository | Institution | 1 |
KTH Royal Institute of Technology - KTH Publication Database DiVA | Other Internet | 1 |